Discovery of ((4R,5S)-5-amino-4-(2,4,5-trifluorophenyl)cyclohex-1-enyl)-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanone (ABT-341), a highly potent, selective, orally efficacious, and safe dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes

被引:44
|
作者
Pei, Zhonghua [1 ]
Li, Xiaofeng [1 ]
von Geldern, Thomas W. [1 ]
Madar, David J. [1 ]
Longenecker, Kenton [1 ]
Yong, Hong [1 ]
Lubben, Thomas H. [1 ]
Stewart, Kent D. [1 ]
Zinker, Bradley A. [1 ]
Backes, Bradley J. [1 ]
Judd, Andrew S. [1 ]
Mulhern, Mathew [1 ]
Ballaron, Stephen J. [1 ]
Stashko, Michael A. [1 ]
Mika, Amanda K. [1 ]
Beno, David W. A. [1 ]
Reinhart, Glenn A. [1 ]
Fryer, Ryan M. [1 ]
Preusser, Lee C. [1 ]
Kempf-Grote, Anita J. [1 ]
Sham, Hing L. [1 ]
Trevillyan, James M. [1 ]
机构
[1] Abbott Labs, Global Pharmaceut Res & Dev, Metab Dis Res, Abbott Pk, IL 60064 USA
关键词
D O I
10.1021/jm060955d
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Dipeptidyl peptidase IV (DPP4) deactivates glucose-regulating hormones such as GLP-1 and GIP, thus, DPP4 inhibition has become a useful therapy for type 2 diabetes. Optimization of the high-throughput screening lead 6 led to the discovery of 25 (ABT-341), a highly potent, selective, and orally bioavailable DPP4 inhibitor. When dosed orally, 25 dose-dependently reduced glucose excursion in ZDF rats. Amide 25 is safe in a battery of in vitro and in vivo tests and may represent a new therapeutic agent for the treatment of type 2 diabetes.
引用
收藏
页码:6439 / 6442
页数:4
相关论文
共 31 条
  • [31] Discovery of 6-(2,4-Dichlorophenyl)-5-[4-[(3S)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7H-benzo[7]annulene-2-carboxylic acid (SAR439859), a Potent and Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen-Receptor-Positive Breast Cancer
    El-Ahmad, Youssef
    Tabart, Michel
    Halley, Frank
    Certal, Victor
    Thompson, Fabienne
    Filoche-Romme, Bruno
    Gruss-Leleu, Florence
    Muller, Claire
    Brollo, Maurice
    Fabien, Laurence
    Loyau, Veronique
    Bertin, Luc
    Richepin, Patrick
    Pilorge, Fabienne
    Desmazeau, Pascal
    Girardet, Chrystelle
    Beccari, Sylvie
    Louboutin, Audrey
    Lebourg, Gilles
    Le -Roux, Jacques
    Terrier, Corinne
    Vallee, Francois
    Steier, Valerie
    Mathieu, Magali
    Rak, Alexey
    Abecassis, Pierre-Yves
    Vicat, Pascale
    Benard, Tsiala
    Bouaboula, Monsif
    Sun, Fangxian
    Shomali, Maysoun
    Hebert, Andrew
    Levit, Mikhail
    Cheng, Hong
    Courjaud, Albane
    Ginesty, Celine
    Perrault, Christelle
    Garcia-Echeverria, Carlos
    McCort, Gary
    Schiot, Laurent
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (02) : 512 - 528